Accelera Innovations

Accelera Innovations FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Accelera Innovations (ACNV) as of Nov 14, 2026 is 11.35 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 0.22 % — a change of 5,036.77% (higher).

FCF Conversion

11.35 %

YoY

5,036.77%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Accelera Innovations is 2016 11.35 % . FCF Conversion Rate (FCF/EBITDA) of Accelera Innovations was 2015 0.22 % . It decreases by 5,036.77% higher compared to the previous year.

The Accelera Innovations FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2014
5.81 USD
Jan 1, 2015
0.22 USD
Jan 1, 2016
11.35 USD
The Accelera Innovations FCF Conversion history
YEARFCF ConversionYoY
11.35 %+5,036.77%
0.22 %-96.19%
5.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accelera Innovations Stock analysis

What does Accelera Innovations do? Accelera Innovations, Inc. generates revenue through its subsidiary SCI Home Health, Inc., operating as Advance Lifecare Home Health, which provides personal care services to patients in the Chicago, Illinois area. The company focuses on acquiring businesses in the post-acute care patient services and information technology services sectors, with SCI Home Health representing its primary healthcare service offering. Revenue is derived from healthcare service contracts within the post-acute care segment, targeting patients requiring ongoing care after hospitalization. The company's business model centers on strategic acquisitions within the healthcare services industry, specifically targeting post-acute care providers and technology service firms. SCI Home Health, Inc. serves as the operational vehicle for delivering personal care services, while the company's acquisition strategy aims to expand its presence in the healthcare sector through targeted investments in complementary businesses. The firm's revenue streams are primarily tied to the delivery of home health services under the Advance Lifecare Home Health brand in the Chicago metropolitan area. Accelera Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accelera Innovations stock

FCF Conversion Rate (FCF/EBITDA) of Accelera Innovations is 11.35 % in 2016.

FCF Conversion Rate (FCF/EBITDA) of Accelera Innovations changed from 0.22 % to 11.35 %, representing a 5,036.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Accelera Innovations since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Accelera Innovations with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Accelera Innovations

All Key Metrics — Accelera Innovations